scroll down

About Dingan


Suzhou Dingan Technology Co., Ltd. was founded by a core team comprising seasoned experts in the fields of biomedical materials and orthopedic implant devices—among them a Fellow of the Royal Society of Biology, a senior visiting scholar who studied in the United States, a member of the Medical and Surgical Materials and Devices Committee and the Additive Manufacturing Technology Committee of the American Society for Testing and Materials, a member of the Orthopedic Implants Sub‑Technical Committee of the National Technical Committee for Standardization of Surgical Implants and Orthopedic Devices, and a member of the Bone Cement and Injectable Materials Specialized Committee of the Chinese Society for Biomaterials—as well as a Jiangsu Province “333 Project” third‑tier trainee and a leading science‑and‑technology entrepreneur in Wujiang City.

 

1999 year

Company establishment

40000 +

Serve customers

5000 Ten thousand plus

Registered capital

25 +

Industry sector

300 +

Company team

Our Advantages



Team and Platform

In collaboration with universities, research institutes, hospitals, testing organizations, and downstream enterprises, the company has jointly submitted applications for major and key national, provincial, and municipal R&D projects. It has established multiple joint consortia dedicated to advancing biomedical materials and high-end orthopedic implant devices, and has set up several joint laboratories focused on the engineering-scale application of critical raw materials for high-end orthopedic implants.

Image Name

Results and Management

Our products uphold a high‑end positioning, stringent standards, and superior quality, ensuring meticulous craftsmanship, outstanding performance, and a modern, eye‑catching design that exudes premium appeal.

Image Name

Equipment and Environment

Meanwhile, leveraging its five cutting-edge technology platforms, the company offers customers customized solutions, material modification, physicochemical property evaluation, biological assessment, and animal studies for bioactive inorganic materials and high-end orthopedic implant devices.

Image Name

Quality service

We provide customers with multi‑dimensional, multi‑layered, and comprehensive value‑added services, including project pre‑research consulting, implementation plan design, engineering and functionalization of prototype products, and personalized customization of biomedical materials.

Image Name
Image Name
Image Name
Image Name
Image Name

Key raw materials for high-end surgical implant devices


The company has consistently focused on the research, development, and production of critical raw materials within the high-end surgical implant device industry chain. Its specialized, customized services now span the entire value chain—R&D, manufacturing, quality control, sales, and clinical application. The company currently offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally. To date, 24 master files for key raw materials used in high‑end surgical implants have been filed and registered with the Medical Device Technical Review Center of the National Medical Products Administration. As a result, the company has become a leading, specialized supplier of critical raw materials, distinguished by its comprehensive product portfolio, cutting-edge manufacturing technologies, and superior product quality in China’s high‑end surgical implant sector. With a cumulative customer base exceeding 200, the company has established itself as an approved supplier to numerous publicly listed companies, industry leaders, renowned universities and research institutes, and top-tier Grade‑III hospitals in the field of high‑end surgical implant products.

The company has consistently focused on the research, development, and production of critical raw materials within the high-end surgical implant device industry chain. Its specialized, customized services now span the entire value chain—research and development, manufacturing, quality control, sales, and clinical application. The company currently offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally. To date, 24 master files for key raw materials used in high‑end surgical implants have been filed and registered with the Medical Device Technical Review Center of the National Medical Products Administration. As a result, the company has become a leading, specialized supplier of critical raw materials, boasting the most comprehensive product portfolio, the most advanced manufacturing technologies, and the highest product quality in China’s high‑end surgical implant manufacturing sector. With a cumulative customer base exceeding 200, the company has established itself as a qualified supplier to numerous publicly listed companies, industry leaders, renowned universities and research institutes, and top-tier Grade‑III hospitals in the field of high‑end surgical implant‑related products.

Key raw-material-derived products and core components for high-end surgical implants


Driven by the growing demand for customized products among key raw material suppliers and customers in the high-end surgical implant device industry chain, the company has, over the years, undertaken the development, customization, and production of critical raw‑material derivatives and core components across multiple specialized market segments. Today, it has become a CDMO service provider to a broad base of clients in the R&D, manufacturing, and application of innovative high‑end implantable devices.

Orthopedics
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, it offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Oral Cavity
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services now spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, the company offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Medical Aesthetics
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services now spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, the company offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Joint
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, it offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Trauma
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services now spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, the company offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Purification
The company has consistently focused on the research and development and production of critical raw materials within the high-end surgical implant device industry chain, with specialized and personalized services now spanning the entire value chain—from R&D and manufacturing to testing, sales, and clinical application. Currently, the company offers over one hundred products across six major product lines—phosphates, silicates, sulfates, bioactive glass, functionalized bioactive materials, and additively manufactured bioactive materials—available for sale both domestically and internationally.
View More
Orthopedics Orthopedics
Oral Cavity Oral Cavity
Medical Aesthetics Medical Aesthetics
Joint Joint
Trauma Trauma
Purification Purification

Partner


Ding’an Technology sincerely looks forward to establishing close partnerships with enterprises at home and abroad, working together to achieve great success!

Blog


Based on the key raw materials for high-end surgical implant devices used in both development and production, the company has established industrial-scale operations across specialized segments including orthopedics, dentistry, medical aesthetics, joint reconstruction, trauma care, and biologics purification. Today, it has become a leading, innovative supplier of core components for China’s high‑end surgical implants, as well as a trusted expert in personalized services, a strategic partner, and a CDMO provider for cutting‑edge orthopedic implant products—serving a broad base of customers across R&D, manufacturing, and clinical application.

Secured another project under the Ministry of Industry and Information Technology’s “Challenge-based Recruitment” initiative.

Relying on its groundbreaking achievements and high level of innovation in the development and industrialization of “nano-hydroxyapatite” within the field of inorganic non-metallic materials, Dingan Technology has once again been selected as the lead entity for an innovative project under the “Challenge‑Based Innovation” initiative. This recognition underscores Dingan Technology’s continued national‑level validation of its technical prowess and innovative capabilities in the biomedical materials sector.

11-04

2025-11-04

2025

The national key special project has successfully passed acceptance.

Dingan Technology, as a key participating institution, has successfully completed the national key R&D program titled “Engineering and Clinical Application of a Novel Injectable Nanobiomaterial for the Prevention and Treatment of Osteoporosis.” The project focuses on the development of an injectable nano‑biomaterial designed to be delivered via minimally invasive procedures directly into specific sites within bone, thereby stimulating the body’s natural osteogenic processes, promoting bone repair and strengthening, and helping to prevent fragility fractures. By guiding the directional deposition of calcium in bone and enhancing the synthesis of bone matrix proteins, this material holds promise for significantly reducing the risk of fractures.

11-04

2025-11-04

2025

Receives ISO 13485 certification again

Dingan Technology has long been committed to the industrialization of critical raw materials, core technologies, and innovative products within the high-end surgical implant device industry chain. The company operates R&D and production facilities for products including “composite ceramic femoral heads,” “zirconia blocks for all-ceramic dentures,” “bioactive materials and high-end bone implants,” and “fillers for medical aesthetic minimally invasive procedures.” It holds manufacturing licenses for “Class III 6846 Implantable Materials and Artificial Organs” and “Class II 17-06 Dental Prosthetic Materials,” and in December 2024, it was further awarded ISO 13485 certification for its medical device quality management system.

11-04

2025-11-04

2025

Suzhou Dingan Technology Co., Ltd. has successfully obtained provincial high-tech enterprise certification.

Warm congratulations to Suzhou Dingan Technology Co., Ltd. on successfully obtaining provincial high-tech enterprise certification…

05-23

2025-05-23

2025

Online Consultation


If you are interested in our products or require samples, please complete the form, and we will contact you promptly.

%{tishi_zhanwei}%